Navigation Links
Wyeth Names Daniel J. McIntyre Vice President, Corporate Communications
Date:9/3/2008

MADISON, N.J., Sept. 3 /PRNewswire-FirstCall/ -- Wyeth (NYSE: WYE) today announced the appointment of Daniel J. McIntyre, 54, to Vice President, Corporate Communications. Reporting to Timothy P. Cost, Senior Vice President, Corporate Affairs, Mr. McIntyre will be responsible for all internal and external communications for the corporation and its three major divisions -- pharmaceuticals, consumer health care and animal health -- around the world.

Prior to joining Wyeth, Mr. McIntyre held a series of senior executive positions in communications and health care. Most recently, he was Managing Director of the healthcare practice of Fleishman-Hillard International Communications. He previously served in senior level Communications and Public Policy positions for Pharmacia Corporation, Bayer Corporation's Pharmaceutical Division, the Bristol-Myers Squibb Company, and Hoffmann-La Roche Inc.

"Wyeth is in one of the most important periods in its history," says Mr. Cost. "We are building momentum toward developing new therapies for patients even as we transform our organization for the future. Having Dan now leading our communications team is an important part of our plan to meet new and evolving challenges."

An honors graduate of Seton Hall University, McIntyre holds an MPA from Rutgers University. He is a member of the executive committee of the Rutgers University Foundation, and has served on the boards of trustees of Caldwell College, the American Association for World Health, the New England Healthcare Institute (NEHI) and Connecticut United for Research Excellence (CURE). He is also a member of the Public Relations Society of America (PRSA).

Wyeth is one of the world's largest research-driven pharmaceutical and health care products companies. It is a leader in the discovery, development, manufacturing and marketing of pharmaceuticals, vaccines, biotechnology products, nutritionals and non-prescription medicines that improve the quality of life for people worldwide. The Company's major divisions include Wyeth Pharmaceuticals, Wyeth Consumer Healthcare and Fort Dodge Animal Health.


'/>"/>
SOURCE Wyeth
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Wyeth and Impax Announce Final Settlement of Effexor XR Patent Suit
2. Wyeths Motion to Overturn Punitive Damages Award Granted by Arkansas Court
3. Wyeth Announces Bernard Poussot Assumes Chairman of the Board Position
4. Wyeth Declares Common and Preferred Stock Dividends
5. Wyeth Pharmaceuticals Announces Organizational Change
6. Intellect Neurosciences, Inc. Grants License for Certain Patents and Patent Applications to Wyeth and Elan Pharma International Ltd.
7. Wyeth to Present at the 2008 Citi Investment Research Global Healthcare Conference
8. Wyeth Research Head Robert R. Ruffolo, Jr., Ph.D., Announces Retirement
9. Wyeth Chairman Robert Essner Announces June 27 Retirement
10. Wyeth and Progenics Receive Positive Opinion From European Committee for RELISTOR for the Treatment of Opioid-Induced Constipation in Advanced-Illness Patients
11. Wyeth to Present at the Lehman Brothers Eleventh Annual Global Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/11/2016)... , Feb. 11, 2016  Spectra BioPharma Selling ... (CSO) that provides biopharma companies the experience, expertise, ... and deploy outsourced sales teams. Created in concert ... addresses both the strategic and tactical needs of ... sales solutions through both personal and non-personal promotion. ...
(Date:2/11/2016)... Florida , February 11, 2016 ... PositiveID Corporation ("PositiveID" or "Company") (OTCQB: PSID), a ... announced today that its Thermomedics subsidiary, which markets ... on its growth plan in January 2016, including ... distributors, increasing sequential monthly sales growth, and establishing ...
(Date:2/11/2016)... ... February 11, 2016 , ... Global ... treatment clinic in Quito, Ecuador. The new facility will provide advanced protocols and ... from around the world. , The new GSCG clinic is headed by ...
(Date:2/10/2016)... , Feb. 10, 2016 NX Prenatal ... its proprietary NeXosome® technology for early warning of ... its most recent study by Dr. Thomas ... the Society for Maternal Fetal Medicine,s (SMFM) annual meeting ... 1-6 th , 2016.  The presentation reported initial ...
Breaking Biology Technology:
(Date:2/3/2016)... LIVERMORE, Calif. , Feb. 3, 2016 ... Police Department in Missouri ... of license plate reader (LPR) data from Vigilant Solutions. ... a hit-and-run case in which the victim was walking out ... a parking space next to his vehicle, striking his ...
(Date:2/2/2016)... NEW YORK , Feb. 2, 2016 ... healthcare facilities are primarily focused on medical ... that measure point-of-care parameters. Wearable devices that ... a user,s freedom of movement are being ... sensors for human biomedical signal acquisition coupled ...
(Date:2/2/2016)... 2016 Checkpoint Inhibitors for Cancer – ... Are you interested in the future of cancer ... inhibitors. Visiongain,s report gives those predictions to 2026 ... level. Avoid falling behind in data or ... revenues those emerging cancer therapies can achieve. There ...
Breaking Biology News(10 mins):